SCHEMBL19984507

SCHEMBL19984507

CC1(C)CCC(c2ncc(COS(C)(=O)=O)s2)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19975474 0.79 LMNA (0.31)
SCHEMBL19975174 0.78 SLC5A2 (0.33)
SCHEMBL19975213 0.78 IDO1 (0.31)
SCHEMBL19975363 0.78 IDO1 (0.31)
Hydrochloric Acid SCHEMBL19975373 0.77 LOXL2 (0.31)
SCHEMBL19975223 0.76 GPR119 (0.34)
SCHEMBL21273290 0.72 GPR119 (0.50)
SCHEMBL19975224 0.72
SCHEMBL9899996 0.70 ALDH1A1 (0.34)
SCHEMBL6625545 0.68 SLC6A3 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220023311-A1 HEPATITIS B CORE PROTEIN MODULATORS ASSEMBLY BIOSCIENCES INC (US) 2022-01-27 US disclosed
US-10987360-B2 Hepatitis B core protein modulators ASSEMBLY BIOSCIENCES, INC. (US) 2021-04-27 US disclosed
US-20190255067-A1 HEPATITIS B CORE PROTEIN MODULATORS ASSEMBLY BIOSCIENCES INC (US) 2019-08-22 US disclosed
WO-2018053157-A1 HEPATITIS B CORE PROTEIN MODULATORS ASSEMBLY BIOSCIENCES, INC. (US) 2018-03-22 WO disclosed